| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.78M | - | |
| VP | 79.5K | $715.6K | - | |
| VP | 67.4K | $606.5K | - | |
| VP | 65.1K | $585.7K | - | |
| VP | 56.3K | $506.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 7,500 | $20.00 | $150,000.00 | -1.0% | |
| Jun 15, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 7,500 | $16.37 | $122,779.31 | -0.5% | |
| Jun 15, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 7,500 | $16.37 | $122,779.31 | -0.5% | |
| Jun 10, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 15,000 | $18.31 | $274,689.75 | -1.1% | |
| Jun 10, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 15,000 | $18.31 | $274,689.75 | -1.1% | |
| May 18, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 15,000 | $19.32 | $289,840.50 | -1.0% | |
| May 18, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 15,000 | $19.32 | $289,840.50 | -1.0% | |
| May 7, 2020 | Frenkel Ran78 | Chief Dev Operations Officer | Sell | 1,974 | $20.00 | $39,480.00 | -5.3% | |
| May 7, 2020 | Primiano Christopher Brett | EVP, Cbo, GC &Secretary | Sale+OE | 9,660 | $19.73 | $190,627.20 | -51.0% | |
| May 7, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 15,000 | $19.63 | $294,414.00 | -1.1% |